Literature DB >> 10082221

Effects of D1 and D2 dopamine receptor antagonists on cocaine-induced self-stimulation and locomotor activity in rats.

K Kita1, T Shiratani, K Takenouchi, H Fukuzako, M Takigawa.   

Abstract

To clarify the involvement of D1 and D2 dopamine systems in intracranial self-stimulation (ICSS) and locomotor activity in rats, we studied the acute effects of cocaine and the interaction between cocaine and dopamine antagonists with respect to these behaviors. Although cocaine (5.0, 10.0, or 20.0 mg/kg) dose-dependently increased locomotor activity, it augmented the rate of ICSS only at 5.0 mg/kg. The failure of high doses of cocaine to augment purpose-oriented behavior such as ICSS may result from its induction of a manic-like state. The D1 dopamine receptor antagonist SCH23390 (0.02, 0.1, or 0.5 mg/kg) or the D2 antagonist nemonapride (0.04, 0.2, or 1.0 mg/kg) significantly decreased cocaine augmentation of ICSS. The higher two doses of either antagonist also produced a significant decrease in cocaine-induced locomotor activity. We therefore suspect that cocaine's augmentative effect on those behaviors, especially ICSS, requires activation of both D1 and D2 dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082221     DOI: 10.1016/s0924-977x(97)00098-9

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  17 in total

Review 1.  Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse.

Authors:  Ivone Gomes; Wakako Fujita; Moraje V Chandrakala; Lakshmi A Devi
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

2.  Stimulation of adenosine receptors in the nucleus accumbens reverses the expression of cocaine sensitization and cross-sensitization to dopamine D2 receptors in rats.

Authors:  Benjamin D Hobson; Kathryn E Merritt; Ryan K Bachtell
Journal:  Neuropharmacology       Date:  2012-06-28       Impact factor: 5.250

3.  PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats.

Authors:  Amanda E Higley; Krista Spiller; Peter Grundt; Amy Hauck Newman; Stephen W Kiefer; Zheng-Xiong Xi; Eliot L Gardner
Journal:  J Psychopharmacol       Date:  2010-02-08       Impact factor: 4.153

4.  Eating high fat chow enhances the locomotor-stimulating effects of cocaine in adolescent and adult female rats.

Authors:  Michelle G Baladi; Wouter Koek; Megan Aumann; Fortino Velasco; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2012-03-15       Impact factor: 4.530

5.  Dopamine D1-D2 receptor Heteromer-mediated calcium release is desensitized by D1 receptor occupancy with or without signal activation: dual functional regulation by G protein-coupled receptor kinase 2.

Authors:  Vaneeta Verma; Ahmed Hasbi; Brian F O'Dowd; Susan R George
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

6.  The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats.

Authors:  Krista Spiller; Zheng-Xiong Xi; Xiao-Qing Peng; Amy H Newman; Charles R Ashby; Christian Heidbreder; József Gaál; Eliot L Gardner
Journal:  Psychopharmacology (Berl)       Date:  2007-11-06       Impact factor: 4.530

7.  Dopamine Regulation of Lateral Inhibition between Striatal Neurons Gates the Stimulant Actions of Cocaine.

Authors:  Lauren K Dobbs; Alanna R Kaplan; Julia C Lemos; Aya Matsui; Marcelo Rubinstein; Veronica A Alvarez
Journal:  Neuron       Date:  2016-05-12       Impact factor: 17.173

8.  Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.

Authors:  Zheng-Xiong Xi; Zheng Yang; Shi-Jiang Li; Xia Li; Christopher Dillon; Xiao-Qing Peng; Krista Spiller; Eliot L Gardner
Journal:  Neuropharmacology       Date:  2007-08-15       Impact factor: 5.250

9.  The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats.

Authors:  Xiao-Qing Peng; Charles R Ashby; Krista Spiller; Xia Li; Jie Li; Nitza Thomasson; Mark J Millan; Elisabeth Mocaër; Carmen Muńoz; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2009-03       Impact factor: 5.250

Review 10.  Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.

Authors:  Rodrigo D Paz; Sonia Tardito; Marco Atzori; Kuei Y Tseng
Journal:  Eur Neuropsychopharmacol       Date:  2008-07-23       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.